HelioLiver LDT now available to order through Quest Diagnostics
Helio Genomics and Microsoft leadership at the Rural Health Transformation Collaborative
News & Media

Collaborating with the Rural Health Transformation Collaborative, Co-Chaired by Microsoft

News May 8, 2026 3 min read Helio Genomics
Share

Excited to announce our important collaboration with the Rural Health Transformation Collaborative, co-chaired by Microsoft.

Helio Genomics, a member of Microsoft for Startups, is proud to contribute to the Rural Health Transformation Collaborative. Together, we are working to expand access to earlier detection for at-risk patients in underserved rural communities.

Liver cancer is one of the fastest-growing causes of cancer deaths in the United States, yet the five-year survival rate remains only about 20%, largely because most cases are detected too late. This is a preventable tragedy, but only if we reach patients in time.

Today, fewer than 20% of high-risk patients receive recommended surveillance. In rural communities, the challenge is even greater, with long travel distances making consistent screening difficult.

Early detection changes outcomes. The CLiMB study, the largest prospective, multicenter U.S. trial of its kind, was published in the Journal of Hepatology on May 6, 2026. It demonstrated that HelioLiver can detect liver cancer at these critical early stages.

Through this collaboration, we aim to bring more accessible, effective surveillance approaches directly into rural care settings. Helio Genomics is developing an epigenomic, blood-based solution designed to enable earlier detection of liver cancer and close the gap in access to care.

For patients, this is transformative. Earlier detection enables more high-risk individuals with cirrhosis to access life-extending and potentially curative therapies, dramatically improving survival rates and quality of life. Rather than facing limited options in advanced disease, they now have a reliable, simple blood-based tool that gives them a real fighting chance.

“The RHT Collaborative is designed to create a future where every rural community has access to high-quality, technology-enabled healthcare. By supporting innovative approaches and care models, collaborations like this help improve access and outcomes for the communities that need them most.”

DRDavid Rhew, M.D.Co-Chair, RHT Collaborative; Global CMO & VP, Health and Life Sciences, Microsoft

“For patients in rural communities, this collaboration represents a step toward more accessible early detection and better outcomes.”

BTBharat TewarieCEO, Helio Genomics

Every patient at risk deserves that chance.

The Rural Health Transformation (RHT) Collaborative is co-chaired by Kyu Rhee, MD, MPP (National Association of Community Health Centers); Brittany Sachdeva (Cibolo Health); James Mault, M.D., FACS (BioIntelliSense, Inc.); and David Rhew, M.D. (Microsoft).

To learn more about Helio Genomics and our work in early detection, visit heliogenomics.com.

View source version on linkedin.com.

Related Articles

More from Helio Genomics

VoicesMay 6, 2026

Bharat Tewarie: Giving Patients a “Real Fighting Chance” Against Liver Cancer

Helio’s CEO reflects on the landmark CLiMB study and what earlier liver cancer detection means for patients.

Read more
Press ReleaseApril 21, 2026

Helio Genomics partners with Syneos Health to accelerate liver cancer detection

A new partnership with Syneos Health to expand access to the HelioLiver blood test and speed up adoption.

Read more
NewsApril 21, 2026

Helio Genomics and Syneos Health Partnership

A new partnership to expand commercialization of the blood-based HelioLiver test for early HCC detection.

Read more